We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Medicago

News List

GSK partners with Medicago to develop plant-based Covid-19 vaccine pharmaceutical-technology
July 08, 2020
GlaxoSmithKline (GSK) has partnered with Canadian biopharmaceutical firm Medicago to develop, assess and manufacture a plant-based adjuvanted Covid-19 vaccine candidate.
Medicago announces production of a viable vaccine candidate for COVID-19 expresspharma
March 27, 2020
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.
Medicago produces viable Covid-19 vaccine candidate pharmaceutical-technology
March 16, 2020
Biopharmaceutical firm Medicago has produced a Virus-Like Particle (VLP) of the novel coronavirus, marking the first step in Covid-19 vaccine development.
Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine americanpharmaceuticacreview
September 27, 2017
Medicago announced the start of a Phase 3 efficacy study for its seasonal quadrivalent influenza vaccine (QIV) candidate.

Previous page 1 2 Next page